DMII

Drugs Made In America Acquisition II Corp. is a shell company operating in the Financial Services sector and Industry of Shell Companies. The company's financial health is characterized by negative profitability, with net income totaling $-455,157 over the trailing twelve months (TTM). Margins are also non-existent, with gross margin, operating margin, and profit margin all recorded at 0.0%. The company's balance sheet shows a current ratio of 0.23, indicating that its current assets are barely sufficient to cover its short-term liabilities. The company's valuation is contextualized by the following metrics: market capitalization stands at $648.54 million; the price-to-book ratio is -37.46; and the cash position totals $315,087.